| 000 | 00922 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513171232.0 | ||
| 264 | 0 | _c19990512 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/S0149-2918(00)88283-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRothermich, E A | |
| 245 | 0 | 0 |
_aProductivity-cost controversies in cost-effectiveness analysis: review and research agenda. _h[electronic resource] |
| 260 |
_bClinical therapeutics _cJan 1999 |
||
| 300 |
_a255-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aEfficiency |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSickness Impact Profile |
| 700 | 1 | _aPathak, D S | |
| 773 | 0 |
_tClinical therapeutics _gvol. 21 _gno. 1 _gp. 255-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0149-2918(00)88283-1 _zAvailable from publisher's website |
| 999 |
_c10050171 _d10050171 |
||